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   The localizations and functions of glutamate and GABA, the major amino acid 
neurotransmitters in the central nervous system, are still unclear in the peripheral 
nervous system. We immunohistochemically double-stained mouse superior cervical 
ganglia with antibodies for the vesicular acetylcholine transporter (VAchT), GAD65, the 
vesicular glutamate transporters 1-3 (VGluTs1-3), the marker of the sympathetic 
preganglionic neuron (SPN), GABAergic, and glutamatergic terminals, respectively. All 
GAD65-positive terminals showed VAchT-immunoreactivity, indicating that GABAergic 
fibers originate from SPNs. VGluT2-immunoreactive terminals showing colocalization 
with VAchT were observed, but VGluT1 and 3 immunoreactive terminals were not. 
Colocalization of GAD65 and VGluT2 was rarely found. All VGluT2-immunopositive 
terminals were also immunopositive for neuronal nitric oxide synthase (nNOS), a 
marker for the subpopulation of the SPNs, while about half of the 
GABA-immunopositive fibers were immunopositive for nNOS. The origin of these fibers 
was discussed. 
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   Sympathetic preganglionic neurons (SPNs) contain not only acetylcholine (Ach), but 
also other neurotransmitters (and/or neuromodulators) including neuropeptides (cf: VIP, 
enkephalin) and bases(cf: ATP). Preganglionic fibers innervate postganglionic neurons 
according to certain rules, known as "chemical coding." 
   Glutamate is  a major excitatory neurotransmitter in the central nervous system. It 
has been reported that there is immunoreactivity for AMPA type glutamate receptor in 
the superior cervical ganglion (SCG) of the rat [13]. Furthermore, glutamate 
synthesising enzyme glutaminase expression has been reported in the autonomic 
preganglionic neurons [17]. However, glutaminase-immunoreactivity was also reported 
in GABAergic interneurons, which might not release glutamate [1]. Therefore, another, 
more reliable marker for glutamatergic neurons was needed to elucidate whether a 
glutamatergic projection to the sympathetic ganglia exists or not.  
   GABA is a major inhibitory neurotransmitter in the central nervous system, and a 
GABAergic projection to the SCG has been reported [4]-[6][21]. Some authors insisted 
there were other neurons innervating postganglionic neurons and that they contained 
GABA [5][21]. For example, Dobo and colleagues [5] argued that SIF-like neurons in the 
sympathetic trunk projected to the SCG, because there were GABA-like 
immunoreactivities observed in fibers of the SCG, SIF-like cells in the sympathetic 
trunk showed a GABA-like immunoreactivity, and there were few GABA-like neurons in 
the spinal cord. Because their argument was based upon indirect evidence, further 
direct evidence is needed to elucidate the source of the GABAergic projection to the 
SCG.  
   The vesicular acetylcholine transporter (VAchT) is a reliable marker for the 
preganglionic terminal because the antibody for VAchT shows very specific staining. 
GAD65 is a better GABAergic terminal marker than GABA itself because the intensity 
of the GABA-like immunoreactivity was the highest when the fixative contained 5% 
glutaraldehyde [4], and this fixative is inadequate of the immunostaining for other 
markers. We used antibodies for vesicular glutamate transporters (VGluTs) because 
these proteins are directly concerned with glutamate exocytosis [18]-[20]. We 
immunohistochemically double-stained the mouse SCGs with antibodies for the VAchT, 
GAD65, and the VGluTs to clarify whether SPNs contain glutamate and/or GABA.    
 
   Twelve male ddY mice were used.  All the animals were maintained and treated 
according to the guidelines established in Fukui Medical University's Guidelines for 
Animal Experiments. Animals were anesthetized with an overdose of chloral hydrate, 
perfused transcardially with 10 ml of saline and then with 40 ml of fixative solution 
containing 4% paraformaldehyde in 0.1M phosphate buffer (pH 7.4). For GABA 
immunohistochemistry, we used a fixative containing 4% paraformaldehyde and 0.05% 
glutaraldehyde in 0.1M phosphate buffer instead. Immediately after perfusion, the 
right SCGs were dissected out and immersed in the same fixative for 1 h at 4oC. SCGs 
were then immersed in 20% sucrose in 0.1M phosphate buffer (pH 7.4) for 24 h. Tissues 
were embedded in the OCT compound (Tissue Tek, USA) and frozen at -80oC. 
Longtitudinal sections 14 grmu m thick were made with a cryostat and mounted on 
glass slides. Sections were incubated overnight with goat anti-VAchT (Chemicon, 
1:1000), rabbit anti-GAD65 (Sigma, USA, 1:1000), rabbit anti-GABA (Sigma, USA, 
1:3000), guinea-pig anti-VGluT1 (1:500), rabbit anti-VGluT2 (1:50), guinea-pig 
anti-VGluT2(1:200), guinea-pig anti-VGluT3 (1:500), rabbit anti-NOS1 (Santa Cruz, 
USA, 1:500), and sheep anti nNOS (1:2000) diluted in 0.3% Triton-X, 1% normal donkey 
serum in  0.05M PBS, followed by Cy3 donkey anti-goat IgG (Jackson 
ImmunoResearch, USA, 1:400), FITC donkey anti-rabbit IgG (Jackson 
ImmunoResearch, USA, 1:200), Cy3 donkey anti-rabbit IgG (Rockland, 1:400, USA), 
Cy3 donkey anti-sheep IgG (Rockland, USA, 1:400), and Cy3 donkey anti-guinea-pig 
IgG (Rockland, USA , 1:400). Sections were observed with a conforcal laser scanning 
microscope (TCS-SP2-AOBS, Leica, Germany) and photographed with a x63 objective 
lens (N.A.=1.4). Antibodies for VGluT1-3 [8][10] were a gift from Dr. Kaneko (Kyoto 
University, Japan). Antibody for nNOS raised from sheep [9] was a gift from Dr. Emson 
(The Babraham Institute, UK). The specificity of antibodies used in this study were 
already examined by other authors with Western blot(VGluT1,2[8], VGluT3[10], 
nNOS[9], NOS1[3], and VAchT[12]) or dot blot(GABA[16]). The specificity of 
anti-GAD65 was examined with Western blot, and we observed single band at 65kD(not 
shown). 
 
   GAD65-immunoreactivity in the SCG had a bouton-like expression. This bouton-like 
expression is the same as in the central nervous system. GAD65-immunopositive 
boutons were scattered throughout the SCG, and sometimes they had a basket-like 
appearance with relatively large postganglionic neurons. We used the term "basket" for 
the condition in which boutons richly surround the cellbody. The number of 
GAD65-immunopositive baskets per one section (12 grmu m thick) were 48.6+/-9.8 (n=5). 
All GAD65-immunopositive boutons exhibited VAchT immunoreactivity (Fig. 1). 
GAD65-immunopositive boutons and nNOS-immunopositive fibers often encircled the 
same postganglionic neurons and were very close to each other (not shown), so that it 
was difficult to judge whether co-localization existed. To overcome this problem, we used 
the anti-GABA antibody instead. Judging the co-localization of GABA and nNOS is 
easier compared to GAD65 and nNOS because the anti-GABA antibody can visualize 
the GABAergic fibers and boutons while the anti-GAD65 antibody visualizes the 
GABAergic boutons only. We found that about half of the GABA-immunopositive fibers 
were also immunopositive for nNOS (Fig. 2). Although the majority of the 
GAD65-immunopositive boutons encircled large NPY-immunonegative postganglionic 
neurons (Fig. 3a), as previously reported in a rat study using the anti-GABA antibody 
[6], about ten-per cent of the NPY-immunopositive neurons were encircled by 
GAD65-immunopositive boutons (Fig. 3b). 
   VGluT1 and 3-immunoreactivities were not found in the SCG, while the control 
sections (cerebral cortex, cerebellum, spinal cord) on the same slide showed marked 
stainings, as reported elsewhere [7][11]. Some VGluT2-immunopositive boutons were 
found in the SCG. In contrast to the GAD65-immunopositive boutons, they were not 
scattered, but gathered around relatively small numbers of postganglionic neurons. The 
number of VGluT2-immunopositive baskets per one section (12 grmu m thick) were 31.6 
+/- 9.6 (n=5). All VGluT2-immunopositive boutons exhibited VAchT-immunoreactivity 
(Fig. 4). All VGluT2-immunopositive boutons also showed nNOS-immunoreactivity (Fig. 
5). VGluT2-immunopositive boutons encircled relatively large NPY-negative 
postganglionic neurons (Fig. 6). 
   Although almost all the GAD65-immunopositive boutons were VGluT2-negative (Fig. 
7), GAD65- and VGluT2-immunopositive boutons often encircled the same 
postganglionic neurons and were very close each other, so that even high magnification 
pictures could not disprove the possibility that some GAD65-immunopositive boutons 
were also immunopositive for VGluT2. However, in serial confocal sections analysis 
(pixel size: 162x162 nm, 0.23 grmu m-thick, 23 optical sections), we found that areas of 
GAD65-immunoreactivity were slightly removed from areas of 
VGluT2-immunoreactivity. Double immunoelectron microscopic observations will help 
whether the colocalization of GAD65 and VGluT2-immunoreactivities exists or not.  
 
   The present study is the first report on VGluT2-immunoreactivity, and shows that 
GAD65- and VGluT2-immunopositive terminals are cholinergic in mouse SCGs. In the 
SCG, ionotropic non-NMDA type glutamate receptor (GluR1 and 2/3) expressions have 
been reported [13], while NR1 subunit (an NMDA receptor component) expression has 
not(unpublished data). The metabotropic glutamate receptor, mGluR7, was shown to be 
expressed [15]. Our findings provide further evidence of the existence of glutamatergic 
transmission in the SCG. VGluT2-immunopositive fibers may originate from SPNs 
because VGluT2-immunopositive terminals also expressed VAchT. Furthermore, 
glutaminase-immunoreactivity was found in SPNs [17].  
   We also found that GABAergic terminals showed cholinergic properties. In previous 
studies, the authors presumed that GABAergic fibers originated from SIF-like cells in 
the cervical sympathetic trunk and cervical sympathetic ganglia [5][21]. However, their 
speculations came from indirect evidence; this being that GABAergic SIF-like cells were 
found in the sympathetic trunk and GABAergic fibers were more aboundunt in the 
rostral sympathetic trunk. Although they stated that GABA-immunopositive neurons 
were not found in the intermediolateral cell column of the spinal cord, the article they 
refered to was inadequate [14] because it dealt with the cervical spinal cord, which does 
not include intermediolateral cell column. Indeed, GABA-immunoreactivity is hardly 
found in the intermediolateral cell column of the normal specimen, but 
GABA-immunopositive SPNs were found in colchicine-treatment animals in our 
preliminary data. Furthermore, it has  not been reported that SIF-like cells have 
cholinergic properties. We also did not observe VAchT-immunopositive SIF-like cells at 
all (data not shown). 
   Nitric oxide-containing neurons are the major subpopulation of SPNs. For example, 
half of the SPNs projecting to the adrenal medulla were immunopositive for nNOS [2]. 
Interestingly, almost all the VGluT2-immunopositive boutons were also immunopositive 
for nNOS, while about half GABA-immunopositive fibers were nNOS-negative. It is 
likely that VGluT2 and GAD65 are chemically distinct populations in the SCG (Fig. 8). 
Although a small number of GAD65-immunopositive boutons encircled NPY-positive 
neurons, the majority of GAD65-immunopositive boutons and almost all 
VGluT2-immunopositive boutons encircled large NPY-negative neurons, indicating that 
these boutons had a week association with vasoconstriction. Future studies will clarify 
the function of these chemically coded pathways. 
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Figure 1-7: Double immunofluorescent micrographs of mouse SCGs. 
 
Figure 1 
All GAD65-immunopositive boutons (red) were also immunopositive for VAchT (green).  
Arrowheads: boutons immunopositive for both GAD65 and VAchT. Bar: 20 grmu m. 
 
Figure 2 
Some GABA-immunopositive fibers were also immunopositive for nNOS (arrowheads), 
while the other GABA-immunopositive fibers were not (arrows). Reconstructed from 
serial 45 images. Green: GABA-immunoreactivity. Red: nNOS-immunoreactivity. Bar: 
10 grmu m. 
 
Figure 3 
a: GAD65-immunopositive boutons (green) were closely appositive to a large 
NPY-negative postganglionic neuron (asterisk). Reconstructed from serial 7 images. b: 
Two NPY-immunopositive postganglionic neurons (+) made close appositions with 
GAD65-immunopositive boutons (green). Red: NPY-immunoreactivity. Bar: 50 grmu m. 
 
Figure 4 
All VGluT2-immunopositive boutons (green) were also immunopositive for VAchT (red). 
Arrowheads: boutons immunopositive for both VGluT2 and VAchT. Bar: 20 grmu m. 
 
Figure 5 
The localization of VGluT2-immunopositivity (green) was consistent with  that of 
nNOS-immunoreactive varicosity (red). Arrowheads: varicosities immunopositive for 
both VGluT2 and nNOS. Bar: 10 grmu m. 
 
Figure 6 
VGluT2-immunoreactive boutons (red) encircled a NPY-negative postganglionic neuron 
(asterisk). Green: NPY-immunoreactivity. Bar: 50 grmu m. 
 
Figure 7 
Colocalizations of GAD65 (green) and VGluT2 (red) were not observed except one 
bouton(arrowhead). Reconstructed from serial 14 images. Bar: 20 grmu m. 
 
Figure 8 
Schematic diagram of the chemical classification of cholinergic fibers in mouse SCGs 
assumed in this study.  

